Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.


Journal

Seminars in cancer biology
ISSN: 1096-3650
Titre abrégé: Semin Cancer Biol
Pays: England
ID NLM: 9010218

Informations de publication

Date de publication:
02 2020
Historique:
received: 01 07 2019
revised: 30 07 2019
accepted: 30 07 2019
pubmed: 14 8 2019
medline: 18 12 2020
entrez: 14 8 2019
Statut: ppublish

Résumé

The development of a myeloid neoplasm is a step-wise process that originates from leukemic stem cells (LSC) and includes pre-leukemic stages, overt leukemia and a drug-resistant terminal phase. Organ-invasion may occur in any stage, but is usually associated with advanced disease and a poor prognosis. Sometimes, extra-medullary organ invasion shows a metastasis-like or even sarcoma-like destructive growth of neoplastic cells in local tissue sites. Examples are myeloid sarcoma, mast cell sarcoma and localized blast phase of chronic myeloid leukemia. So far, little is known about mechanisms underlying re-distribution and extramedullary dissemination of LSC in myeloid neoplasms. In this article, we discuss mechanisms through which LSC can mobilize out of the bone marrow niche, can transmigrate from the blood stream into extramedullary organs, can invade local tissue sites and can potentially create or support the formation of local stem cell niches. In addition, we discuss strategies to interfere with LSC expansion and organ invasion by targeted drug therapies.

Identifiants

pubmed: 31408723
pii: S1044-579X(19)30214-7
doi: 10.1016/j.semcancer.2019.07.025
pmc: PMC7115853
mid: EMS87366
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-201

Subventions

Organisme : Austrian Science Fund FWF
ID : F 4704
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 30625
Pays : Austria

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict to disclose in this study.

Références

Eur J Haematol. 1999 Sep;63(3):192-201
pubmed: 10485274
Clin Cancer Res. 2016 Apr 15;22(8):2051-61
pubmed: 26607600
Int J Mol Sci. 2019 Feb 12;20(3):
pubmed: 30759825
Front Oncol. 2017 Nov 06;7:263
pubmed: 29164062
Oncotarget. 2016 May 31;7(22):32532-42
pubmed: 27081038
Leuk Lymphoma. 1994 Jun;14(1-2):19-28
pubmed: 7522718
Ther Adv Hematol. 2016 Feb;7(1):40-51
pubmed: 26834953
Blood. 2008 Aug 1;112(3):568-75
pubmed: 18523148
Blood Cells Mol Dis. 2016 Nov;62:42-48
pubmed: 27865175
Blood. 2001 Dec 15;98(13):3784-92
pubmed: 11739187
Heart. 2018 Dec;104(24):1995-2002
pubmed: 30228246
Stem Cells. 2004;22(2):188-201
pubmed: 14990858
Blood. 2004 May 15;103(10):3883-9
pubmed: 14726393
Leukemia. 2018 Mar;32(3):575-587
pubmed: 28816238
Trends Genet. 1993 Apr;9(4):138-41
pubmed: 8516849
Nat Med. 2006 Oct;12(10):1167-74
pubmed: 16998484
Leukemia. 2005 Mar;19(3):435-41
pubmed: 15674418
Front Immunol. 2015 May 26;6:235
pubmed: 26074915
Blood. 2007 Oct 1;110(7):2659-66
pubmed: 17609428
Cell Stem Cell. 2015 Mar 5;16(3):254-67
pubmed: 25748932
Biochem Pharmacol. 2010 Sep 1;80(5):602-12
pubmed: 20382130
Cold Spring Harb Perspect Med. 2017 Dec 1;7(12):
pubmed: 28490542
Lancet. 2000 May 13;355(9216):1688-91
pubmed: 10905245
Nat Med. 2006 Oct;12(10):1175-80
pubmed: 16998483
Stem Cells Transl Med. 2013 Feb;2(2):143-50
pubmed: 23349328
Ann Hematol. 2018 May;97(5):763-772
pubmed: 29392425
Stem Cells Dev. 2012 Aug 10;21(12):2142-51
pubmed: 22121892
Cell Stem Cell. 2016 Jul 7;19(1):23-37
pubmed: 27374788
Nat Rev Cancer. 2007 Jun;7(6):441-53
pubmed: 17522713
Trends Cell Biol. 1999 Dec;9(12):M57-60
pubmed: 10611684
Am J Blood Res. 2013 Dec 18;3(4):265-70
pubmed: 24396704
Leukemia. 2018 May;32(5):1116-1123
pubmed: 29556022
Blood. 2018 Nov 1;132(18):1936-1950
pubmed: 30018080
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16280-5
pubmed: 20805474
J Clin Oncol. 2011 Feb 10;29(5):591-9
pubmed: 21220598
Cancer Res. 2013 Feb 1;73(3):1037-45
pubmed: 23345162
Blood. 2015 Feb 5;125(6):901-6
pubmed: 25525119
Annu Rev Genet. 2014;48:215-36
pubmed: 25292359
Leukemia. 1997 Jun;11(6):822-9
pubmed: 9177435
Am J Hematol. 2016 May;91(5):507-17
pubmed: 26822317
Oncotarget. 2013 May;4(5):715-28
pubmed: 23651669
Nat Rev Cancer. 2017 Jan;17(1):5-19
pubmed: 27834397
Lab Invest. 1990 Jan;62(1):5-33
pubmed: 2404155
Leukemia. 2012 May;26(5):985-90
pubmed: 22182920
Blood Cancer J. 2017 Mar 10;7(3):e542
pubmed: 28282031
Leukemia. 2005 Mar;19(3):373-80
pubmed: 15674360
Allergy Asthma Clin Immunol. 2009 Dec 07;5(1):13
pubmed: 20066174
Stem Cells Dev. 2009 Oct;18(8):1235-42
pubmed: 19105599
N Engl J Med. 2015 Jul 9;373(2):163-72
pubmed: 26154789
Leukemia. 2000 Jul;14(7):1239-46
pubmed: 10914548
Leuk Lymphoma. 2017 Jun;58(6):1455-1467
pubmed: 27733071
Blood. 2005 Feb 1;105(3):986-93
pubmed: 15459012
Cancer Cell. 2014 Jun 16;25(6):778-93
pubmed: 24937459
Nat Med. 2003 Sep;9(9):1158-65
pubmed: 12897778
Expert Opin Drug Saf. 2019 Jun;18(6):485-496
pubmed: 31062991
Blood. 2003 Jun 15;101(12):4680-6
pubmed: 12576320
Exp Hematol. 2002 Sep;30(9):973-81
pubmed: 12225788
Am J Hematol. 2011 Jan;86(1):31-7
pubmed: 21132730
Blood. 2014 Feb 27;123(9):1361-71
pubmed: 24394666
Blood. 2017 Jul 27;130(4):397-407
pubmed: 28576879
Eur J Clin Invest. 2007 Jan;37(1):73-82
pubmed: 17181570
Br J Haematol. 1993 Oct;85(2):285-91
pubmed: 7506565
Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267
pubmed: 28342811
J Clin Oncol. 2013 Feb 20;31(6):e90-7
pubmed: 23129735
Stem Cells. 2002;20(3):259-66
pubmed: 12004084
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098
Br J Haematol. 1996 May;93(2):367-74
pubmed: 8639430
Blood. 2002 Mar 15;99(6):2265-7
pubmed: 11877311
Pediatr Blood Cancer. 2017 Aug;64(8):
pubmed: 28409853
Eur J Clin Invest. 2018 Oct;48(10):e13000
pubmed: 30019447
Nat Immunol. 2004 Jul;5(7):738-43
pubmed: 15170211
Leukemia. 2009 Apr;23(4):679-85
pubmed: 19158834
Cancer Cell. 2018 Oct 8;34(4):674-689.e8
pubmed: 30245083
Leuk Lymphoma. 1996 Apr;21(3-4):201-9
pubmed: 8726400
Cancer Treat Res. 2001;108:185-230
pubmed: 11702600
Cancer Cell. 2014 Jun 16;25(6):794-808
pubmed: 24835589
Haematologica. 2017 Oct;102(10):e389-e393
pubmed: 28619846
Leukemia. 2017 Dec;31(12):2702-2708
pubmed: 28663577
Immunol Today. 1994 Mar;15(3):111-4
pubmed: 7513517
Neoplasia. 2012 Jul;14(7):572-84
pubmed: 22904675
Leuk Lymphoma. 2006 Feb;47(2):207-22
pubmed: 16321850
Am J Cancer Res. 2013 Apr 03;3(2):159-72
pubmed: 23593539
EBioMedicine. 2017 Dec;26:17-24
pubmed: 29203377
Cell. 1994 Jan 28;76(2):301-14
pubmed: 7507411
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11008-13
pubmed: 17576927
Cancer Res. 2010 Jan 15;70(2):447-52
pubmed: 20068184
N Engl J Med. 2004 Aug 12;351(7):657-67
pubmed: 15306667
Am Soc Clin Oncol Educ Book. 2019 Jan;39:400-410
pubmed: 31099654
PLoS One. 2008 Mar 19;3(3):e1826
pubmed: 18350162
Leukemia. 2019 Nov;33(11):2673-2684
pubmed: 30953030
Acta Haematol. 2001;106(4):170-6
pubmed: 11815714
Stem Cells Dev. 2011 Jun;20(6):933-46
pubmed: 21186999
Nat Commun. 2019 Jan 21;10(1):366
pubmed: 30664659
Leuk Lymphoma. 2004 Sep;45(9):1887-97
pubmed: 15223651
Eur J Immunol. 2017 Sep;47(9):1501-1512
pubmed: 28736941
Exp Hematol. 2014 Nov;42(11):976-986.e3
pubmed: 25179751
Science. 2008 Dec 19;322(5909):1861-5
pubmed: 19095944
Am J Case Rep. 2016 Oct 27;17:793-798
pubmed: 27784881
Mol Cancer Ther. 2008 Jan;7(1):48-58
pubmed: 18202009
Cell Death Dis. 2012 Oct 04;3:e396
pubmed: 23034331
Blood. 2012 Apr 26;119(17):3917-24
pubmed: 22308295
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Br J Haematol. 2008 Dec;143(5):622-31
pubmed: 19036013
Cell Mol Immunol. 2006 Oct;3(5):359-65
pubmed: 17092433
Br J Haematol. 2009 Jun;145(6):836-8
pubmed: 19388942
Oncotarget. 2016 May 31;7(22):33016-24
pubmed: 27145281
Adv Cancer Res. 2019;141:85-128
pubmed: 30691686
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
Cytometry. 1997 Apr 15;30(2):98-102
pubmed: 9149916
PLoS One. 2014 Apr 03;9(4):e93173
pubmed: 24699049
J Immunol. 2013 Nov 15;191(10):5304-16
pubmed: 24127558
Leuk Res. 2001 Oct;25(10):847-53
pubmed: 11532516
Blood. 1996 Sep 15;88(6):2162-71
pubmed: 8822936
Mol Pathol. 1999 Aug;52(4):189-96
pubmed: 10694938
J Clin Oncol. 2008 Jun 10;26(17):2911-5
pubmed: 18539972
Jpn J Cancer Res. 1996 Oct;87(10):1070-7
pubmed: 8957066
Adv Pharmacol. 1994;25:117-69
pubmed: 7515640
Leukemia. 2017 Nov;31(11):2388-2397
pubmed: 28757617
Exp Hematol. 2018 Jan;57:50-59.e6
pubmed: 29031704
Eur J Clin Invest. 2014 Dec;44(12):1239-45
pubmed: 25371066
Leukemia. 2005 Jan;19(1):57-63
pubmed: 15510209
Haematologica. 2012 Feb;97(2):219-26
pubmed: 21993666
Curr Cancer Drug Targets. 2011 Nov;11(9):1053-68
pubmed: 21999626
Blood Adv. 2017 Jun 13;1(14):972-979
pubmed: 29296739
Ann N Y Acad Sci. 2020 Apr;1466(1):24-38
pubmed: 31006885
Stem Cells. 2005 Aug;23(7):879-94
pubmed: 15888687
J Cell Sci. 2018 Jan 10;131(1):
pubmed: 29180515
Blood. 2005 Apr 1;105(7):2733-40
pubmed: 15591120
Cell Stem Cell. 2018 Jan 4;22(1):64-77.e6
pubmed: 29276143
Cancer Cell. 2017 Sep 11;32(3):324-341.e6
pubmed: 28870739
Blood. 2009 Jun 11;113(24):6206-14
pubmed: 19050309
Blood. 2011 Mar 3;117(9):2700-7
pubmed: 21212285
Haematologica. 2015 Nov;100(11):1376-87
pubmed: 26521296
Curr Top Med Chem. 2007;7(14):1379-93
pubmed: 17692027
Cell. 2009 Jul 23;138(2):286-99
pubmed: 19632179
Int J Hematol. 2016 May;103(5):567-71
pubmed: 26910244
Blood. 2012 Sep 27;120(13):2658-68
pubmed: 22889761
Science. 2004 Aug 13;305(5686):1000-3
pubmed: 15310902
Exp Hematol. 2015 Dec;43(12):989-92
pubmed: 26455528
Curr Hematol Malig Rep. 2015 Jun;10(2):126-31
pubmed: 25921388
Adv Exp Med Biol. 2012;741:152-70
pubmed: 22457109
Nat Rev Cancer. 2012 Nov;12(11):767-75
pubmed: 23051844
PLoS One. 2013 Jul 26;8(7):e70139
pubmed: 23922938
Oncogenesis. 2015 Apr 13;4:e146
pubmed: 25867177
Blood. 2000 Sep 15;96(6):2240-5
pubmed: 10979972
Cancer Res. 2017 Mar 15;77(6):1261-1270
pubmed: 28254862
Haematologica. 2000 Feb;85(2):139-46
pubmed: 10681720
Ann Hematol. 1992 Oct;65(4):169-74
pubmed: 1384721
Leuk Res. 1996 Nov-Dec;20(11-12):905-8
pubmed: 9009247
J Clin Invest. 2006 Mar;116(3):652-62
pubmed: 16498499
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Ann N Y Acad Sci. 2007 Jun;1106:1-19
pubmed: 17360804
Cell Stem Cell. 2013 Sep 5;13(3):285-99
pubmed: 23850243
Blood. 1998 Jun 15;91(12):4523-30
pubmed: 9616148
Leukemia. 2012 May;26(5):977-84
pubmed: 22157734
Blood. 2004 Jan 1;103(1):110-9
pubmed: 12958067
Blood. 2014 Jun 19;123(25):3951-62
pubmed: 24778155
Blood. 2004 Jul 1;104(1):65-72
pubmed: 15010367
Blood. 2002 Nov 15;100(10):3767-75
pubmed: 12393646
Transfusion. 2005 Jul;45(7):1192-200
pubmed: 15987366
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609
Cancer Res. 2004 Apr 15;64(8):2817-24
pubmed: 15087398
Blood. 2015 Jul 2;126(1):9-16
pubmed: 25931582

Auteurs

Peter Valent (P)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Austria. Electronic address: peter.valent@meduniwien.ac.at.

Irina Sadovnik (I)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Austria.

Gregor Eisenwort (G)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Austria.

Harald Herrmann (H)

Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Austria; Department of Radiotherapy, Medical University of Vienna, Department of Medicine III, Austria.

Karin Bauer (K)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Austria.

Niklas Mueller (N)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Department of Internal Medicine III, Division of Hematology and Oncology, Hospital of the Ludwig-Maximilians-University Munich, Germany.

Wolfgang R Sperr (WR)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Austria.

Daniel Wicklein (D)

Institute of Anatomy and Experimental Morphology, University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Udo Schumacher (U)

Institute of Anatomy and Experimental Morphology, University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH